Avior Wealth Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,718
| Closed | -$175K | – | 1114 |
|
|
2024
Q4 | $175K | Sell |
3,718
-281
| -7% | -$13.2K | 0.01% | 744 |
|
|
2024
Q3 | $211K | Buy |
3,999
+1,454
| +57% | +$76.8K | 0.01% | 681 |
|
|
2024
Q2 | $138K | Sell |
2,545
-184
| -7% | -$9.97K | 0.01% | 777 |
|
|
2024
Q1 | $191K | Buy |
+2,729
| New | +$191K | 0.01% | 721 |
|
|
2023
Q4 | – | Sell |
-330
| Closed | -$9.72K | – | 1550 |
|
|
2023
Q3 | $9.72K | Hold |
330
| – | – | ﹤0.01% | 1049 |
|
|
2023
Q2 | $10.8K | Hold |
330
| – | – | ﹤0.01% | 1016 |
|
|
2023
Q1 | $11.6K | Hold |
330
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q4 | $15.1K | Hold |
330
| – | – | ﹤0.01% | 795 |
|
|
2022
Q3 | $15K | Hold |
330
| – | – | ﹤0.01% | 784 |
|
|
2022
Q2 | $12K | Hold |
330
| – | – | ﹤0.01% | 742 |
|
|
2022
Q1 | $12K | Hold |
330
| – | – | ﹤0.01% | 798 |
|
|
2021
Q4 | $15K | Buy |
+330
| New | +$15K | ﹤0.01% | 751 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$1K | – | 1077 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 946 |
|
|
2021
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 903 |
|
|
2018
Q2 | – | Sell |
-175
| Closed | -$1K | – | 794 |
|
|
2018
Q1 | $1K | Hold |
175
| – | – | ﹤0.01% | 718 |
|
|
2017
Q4 | $1K | Buy |
175
+30
| +21% | +$171 | ﹤0.01% | 721 |
|
|
2017
Q3 | $3K | Sell |
145
-30
| -17% | -$621 | ﹤0.01% | 417 |
|
|
2017
Q2 | $2K | Buy |
+175
| New | +$2K | ﹤0.01% | 408 |
|
|
2014
Q2 | – | Sell |
-260
| Closed | -$2K | – | 328 |
|
|
2014
Q1 | $2K | Buy |
+260
| New | +$2K | ﹤0.01% | 310 |
|